Initiative for MPT Talk Series Continues
The Initiative for MPTs (IMPT) discussion series called "Let's Talk MPTs" is aimed at benefiting multipurpose prevention technologies (MPT) researchers and increasing interest in the MPTs among newer stakeholders. The series will cover an array of topics including socio-behavioral and market research, toxicity studies, policy and advocacy, and more.
On Thursday, June 30 at 10:30 AM EST this series will continue with a webinar held in partnership between the Initiative for MPTs (IMPT) and Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence (MATRIX) and focused on patenting and intellectual property considerations for MPTs. Speakers include Akash Bakshi (YourChoice Therapeutics, Inc.), Ian McGowan (Orion Biotechnology), Lobna Gaayeb (Medicines Patent Pool), and Nataliya Omelchuk (Medicines Patent Pool). Register here for the event.
Missed a previous discussion? Check out the recordings:
Integrating End-User Research in Product Development & Commercialization Strategies with Moushira El-Sahn (Routes2Results), Andrea Thurman (CONRAD), Liz Pinto (Evofem Biosciences, Inc.), and Karina Fedasz (Evofem Biosciences, Inc.)
MPT Regulatory Pathways - Case Studies from MPT Product Developers with Mary Weitzel, MBA (Yaso Therapeutics), Daniel Loeven, MS (Population Council), and Wilberto Robles, MCC, MTOPRA (WCG Cares)
Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches with Rahima Benhabbour (University of North Carolina Chapel Hill), Courtney Jarrahian (PATH) and Joseph Romano (NWJ Group)
Combining Active Pharmaceutical Ingredients (APIs): MPT Development & Regulatory Considerations with Deven Shah (Certara), Kevin Hershberger (Certara), and Tamra Goodrow (Deer Run Regulatory Consulting)
Toxicity Study Considerations for MPT and HIV Prevention R&D with Tom Moench (Mucommune) and Miles ( ZabBio)
Integrating Socio-behavioral & Market Research into MPT R&D with Betsy Tolley (FHI 360), Deborah Anderson (Boston University School of Medicine), Mary Weitzel (Yaso Therapeutics), Matthew Quaife (London School of Hygiene & Tropical Medicine), Khatija Ahmed (Setshaba Research Centre), and Joseph Murungu (Pangaea Zimbabwe AIDS Trust)
The Role of Cervicovaginal Microbiota on Contraceptive and MPT Development with Jacques Ravel, PhD, MSc (University of Maryland) and Jennifer Deese, PhD, MPH (RTI International)